Estimated reading time at 200 wpm: 9 minutes

The latest National Audit Office (NAO) report on prison drugs quantifies a reality already obvious to those in forensic psychiatry and custodial care [1]. The data shows millions in unspent budgets and decade-long delays for basic security. It depicts a system that is currently more effective at fostering addiction than supporting recovery. We are trying to fight 21st-century organised crime and high-potency synthetic opioids with a Victorian infrastructure that is struggling to stay functional.

1. The Chemistry of Despair: From Spice to Nitazenes

Drug use in prisons has shifted from recreational to survivalist. The current landscape is a sophisticated chemical arms race that the state is demonstrably losing.

The “Bird-Killer” Phenomenon: Why the Market is Desperate

In clinical settings, these substances are often called “bird-killers.” This is a functional description. When individuals are confined to cells for 22 hours a day because of staffing gaps or overcrowding, drugs like Spice or Nitazenes “kill the bird” (prison time). They induce semi-consciousness or dissociation [2]. The demand isn’t driven by pleasure. It is driven by the unbearable vacuum of idle time. The NAO report highlights that 11% of men and 19% of women develop a drug problem after entering the system. The environment itself is a primary driver of addiction [1].

The Secondary Trauma: Staff Exposure and “Code Blue” Normalization

The current drug “menu” is more potent than ever. Moving from Spice to synthetic opioids like Nitazenes—which can be 50 to 500 times stronger than morphine—creates a high-stakes environment [3]. “Code Blue” medical emergencies, where a person stops breathing, are now a near-daily occurrence in high-risk sites. This frequency has led to staff suffering from “secondary exposure” and a troubling desensitisation toward medical emergencies [4]. Between December 2022 and December 2024, 16% of all deaths in custody (136 people) were drug-related [1].

The Detection Gap: Why Traditional Testing is Failing

Organised crime networks are outmanoeuvring current testing regimes. Drone activity rose by 43% in a single year and 750% since 2019. This enables the delivery of bespoke chemical packages [1]. These synthetic opioids are often colourless and odourless. They can be impregnated into paper, making them almost impossible to find with standard searches or X-ray scanners. The NAO also found that 40% of prisons lacked complete training records for scanning equipment. About one-third could not prove they were performing required quality checks [1].

2. A Decade of “Broken Record” Recommendations

The 2026 NAO report generates a profound sense of déjà vu. This crisis has been forecast in the same terms for a decade, but the response remains trapped in bureaucratic inertia.

The 2016-2026 Timeline: Why Nothing Actually Changes

Comparisons between the 2016 Chief Inspector’s report and today’s findings show a largely unchanged script. In 2016, we were warned that the shift to New Psychoactive Substances (NPS) was already undermining the mandatory drug testing system [4]. Ten years later, the government response to the Justice Committee inquiry accepted only 8 of 29 recommendations in full. Most were “partially accepted,” which is often a way to acknowledge a problem without committing to a timeline or budget [3].

The Bureaucratic Bottleneck: Where Funding Stalls

Despite public announcements of “record investment,” the reality is chronic underspending. Between 2022 and 2025, HMPPS was allocated £114 million for drug strategy initiatives. Only 69% of that budget was actually spent [1]. Delays in ministerial sign-off frequently waste the first quarter of the financial year. This leads to Drug Recovery Wings that never open and clinical roles that remain vacant. Only seven of the planned 18 specialised wings ever became operational [1].

The Maintenance Paradox: Infrastructure as a Security Risk

Victorian-era buildings currently facilitate smuggling. The maintenance backlog across the estate doubled to £1.8 billion between 2020 and 2024 [1]. In various sites, work to prevent drone access—like netting and window reinforcements—has been delayed for years because of the complexities of listed buildings. HMPPS has indicated that some work deemed urgent in 2021 may not be finished until 2031 [1].

3. The State’s Defence: Strategy, Technology, and Capacity

It would be a mistake to suggest the government is inactive. There is a clear strategy on paper, and in some areas, significant technical progress has been made. The issue is whether these “top-down” successes are being cancelled out by “bottom-up” systemic decay.

The Technological “Arms Race”: Scanners and No-Fly Zones

The government has invested heavily in hardware to close the detection gap. Over 75 X-ray body scanners have been rolled out across the adult male estate to detect internally smuggled items [5]. Officials argue that this tech is finally shining a light on previously invisible smuggling routes. Furthermore, the introduction of 400-metre “No-Fly Zones” around prisons—formalised under the Air Navigation (Restriction of Flying) (Prisons) Regulations and supported by the Sentencing Act 2026—is a direct attempt to legislate against the drone threat [6].

The “From Harm to Hope” Ambition

The 10-year strategy launched in 2021 was the first of its kind to explicitly link supply reduction with treatment demand [7]. While the NAO highlighted the underspend, the government maintains that the intent is transformative. They point to successes in community-based treatment numbers and the “Integrated Offender Management” programmes designed to break the link between addiction and acquisitive crime.

The Capacity Crisis: Building Out the Problem

The Ministry of Justice often argues that stability is impossible in overcrowded conditions. Their primary defence is the ongoing prison-building programme, aimed at delivering 14,000 new places by the end of the decade [5]. Modern sites like HMP Five Wells are designed with “drug-free” principles in mind—better lines of sight, modern healthcare suites, and more secure windows. The argument is that once the population pressure is eased by these new builds, the rest of the drug strategy will finally have the “breathing room” it needs to work.

4. The “Winning the War” Question: Progress or Managed Decline?

It is still early to call the final outcome, but the current indicators are mixed at best. The government points to “finds” as proof of success, but the reality on the wings tells a different story.

The Finds Paradox: More Catches, More Drugs

In 2024-25, HMPPS reported 26,348 drug find incidents—a 25% increase from the previous year [1]. While this could be seen as a victory for better security and X-ray scanners, it sits alongside a massive jump in drug availability. The proportion of prisoners reporting that it is “easy” to get drugs increased from 24% to 39% in just three years [1, 2]. We are catching more because there is simply more to catch. The market has grown faster than our ability to police it.

The Ceded Airspace

One of the most sobering admissions in recent reports is that at several high-security sites, the prison service has effectively “ceded the airspace” to criminals [3]. While “No-Fly Zones” are now law, drone sightings increased by 43% in the last year alone [1]. The 2026 NAO report makes it clear that we are attempting to fight this with 2021 maintenance contracts that are failing to deliver netting and window grilles on time. We are losing the technological war to the agility of organised crime.

Treatment: The Statistical Sleight of Hand

There is a genuine success story in treatment numbers: over 52,000 adults were in drug and alcohol treatment in prisons last year, a 5% increase [8]. However, this “growth” is overshadowed by the funding reality. The NAO found that real-term spending on these services actually fell by 5% since 2020 when adjusted for inflation [1]. We are treating more people with less money, leading to a “postcode lottery” where spending per head varies by 72% between regions [1].

5. The Clinical Reality vs. The Policy Vacuum

Policy debate usually prioritises security. However, clinical evidence suggests the crisis is fueled by a lack of therapeutic engagement and a shrinking resource base.

The 22-Hour Lockup: Breeding Grounds for Addiction

Rehabilitation is impossible in a state of sensory deprivation. When staff numbers drop, education, gym access, and association are the first services to go. This leaves people in 22-hour lockups where the mental health toll is immense. In these conditions, drugs are a coping mechanism for an environment that has become pharmacologically survivalist [2].

The Lost Appointments: The Guard Shortage as a Clinical Barrier

Approximately 160,000 substance misuse appointments went unattended in 2024-25. That is about 35% of all scheduled clinical contact [1]. A huge portion of this is due to lockdowns or a lack of escorts. Even when clinicians and patients are in the same building, the absence of staff to facilitate movement prevents care from happening.

6. The Professional Impasse: A System of Managed Failure

For those of us working in the clinical spaces of these prisons, the NAO report confirms a growing professional frustration. We are often tasked with delivering complex psychiatric care in an environment that is fundamentally hostile to health. When 35% of appointments are missed because of staffing, the clinical work becomes an exercise in managed failure. We are not just treating addiction; we are treating the fallout of a system that has allowed drugs to become the primary currency of time management for its inmates.

7. Looking Toward 2036: The Road Beyond Sticking Plasters

The 2026 report demonstrates that drone-proofing alone is not the answer. As long as 22-hour lockups, crumbling wings, and shrinking clinical budgets persist, the drug economy will thrive. This is a public health crisis housed within a decaying security infrastructure. The government has the strategy on paper, but the execution is being swallowed by the physical and bureaucratic weight of the estate. If the response continues to be selective, and if millions in allocated funds continue to go unspent, we are essentially marking time until the next report tells us the exact same thing in another ten years.

References

1. National Audit Office (2026): The Costs of Tackling Drug Harms in Prisons
2. Prison Reform Trust: Bromley Briefings Prison Factfile (Winter 2025)
3. UK Government: Response to the Justice Committee’s Inquiry on Drugs in Prison (Jan 2026)
4. HM Inspectorate of Prisons: Annual Report 2024-25
5. Ministry of Justice: Prison Security and Capacity Update (2025)
6. Civil Aviation Authority: Restricted Airspace for Prisons and Young Offender Institutions (2025)
7. HM Government: From Harm to Hope: A 10-year drugs strategy (2021)
8. GOV.UK Statistics: Alcohol and drug treatment in secure settings 2024 to 2025